Breaking News

RFK Jr. returns to the spotlight. GOP works on unresolved Medicaid policies.

May 20, 2025
john-wilkerson-avatar-teal
Washington Correspondent, D.C. Diagnosis Writer

Last week, two House committees pulled all-nighters. This week promises a similar schedule. Cue the mocking air violins. Tip jar: John.Wilkerson@statnews.com or over Signal at John_Wilkerson.07.

calendar items

No rest for the sleepy

Like last week, this week started Sunday night. At around 11 p.m., Republicans on the House Budget Committee passed their One Big Beautiful Bill, which includes $715 billion in federal Medicaid funding cuts, plus an overhaul to the rules for state Affordable Care Act insurance marketplaces. 

Next stop, the House Rules Committee, which is scheduled to mark up the big 'ol beauty of a bill on Wednesday at 1 a.m. (that's not a typo). House Speaker Mike Johnson (R-La.) plans for the House to pass the bill by the end of the week. 

It's an aggressive timeline for major legislation. Normally, that would be enough to keep Washington busy, but there's plenty more happening. Today, HHS Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Appropriations Committee (see more below), and on Thursday FDA Commissioner Marty Makary is scheduled to get his turn before that committee.

But first, Makary is expected to release the FDA's vaccine framework, which will focus on Covid-19 vaccines, today. Tomorrow, the Senate Homeland Security and Governmental Affairs Committee is scheduled to hold a hearing on Covid-19 vaccine safety. 

The Make America Healthy Again Commission could release its initial assessment on the potential contributors to childhood chronic disease and the state of chronic disease prevalence, treatment, and research.


appropriations

Kennedy returns to the Senate spotlight

Kennedy will face questions about his HHS cuts as he goes before the Senate today, Daniel Payne reports. 

In a hearing about the Trump administration's budget proposal, Democrats on the Senate Appropriations Subcommittee that oversees HHS plan to press Kennedy on the cuts at the department and for research grants.

Sen. Patty Murray (D-Wash.), who is on the subcommittee and ranking member of the full committee, will ask Kennedy about the recent cuts and argue against further cuts that are being proposed, a Murray aide told STAT. She'll also urge her colleagues to stand up to the changes.

"If we don't, decades of scientific breakthroughs and medical discovery, and the bipartisan work to support them, risks being burned to the ground — and it will be very hard to rebuild," she plans to say.

But whether Republicans on the subcommittee will heed Murray's call is unclear. None of their offices immediately responded to requests for comment. Though some GOP lawmakers have shown discomfort with parts of Kennedy's agenda, they have mostly embraced his reforms.



medicaid

Unresolved Medicaid policies

The Budget Committee's late-night vote was necessary because the committee failed to pass the same bill on Friday over conservatives' demands for changes to it, some of which involve Medicaid. 

The bill includes a strict Medicaid work requirement policy, but it doesn't start until 2029, after the next presidential election. Republicans in the far-right House Freedom Caucus want to impose the policy as soon as possible, and they may very well get their way.

The bill that passed Sunday night remained unchanged from the version that failed Friday, but conservatives believe they made sufficient progress over the weekend to change their votes to present, instead of voting no, which was just enough to advance it. Read more.


maha

MAHA Commission Report

The MAHA Commission is supposed to produce a report outlining the biggest health problems facing the nation. But the epidemic takes on a different tone depending on what you focus on.

If you were on the commission, what priorities would you choose? STAT's Isabella Cueto and J. Emory Parker pored over dozens of studies, policy papers, commentaries and federal guidance documents, interviewed experts and analyzed reams of data to break down the U.S. chronic disease crisis into 9 buckets — from reducing healthcare spending to targeting the biggest issues in red states, and beyond.

See the story (and its many cool charts) for yourself, and keep an eye out tomorrow for three big ideas to actually "MAHA." 


fda

From sports medicine doctor to top vaccine adviser

Lizzy Lawrence has a top-notch profile of a top adviser to the FDA who has mostly flown under the radar.  

Tracy Beth Høeg was a sports medicine physician focused on ultramarathon runners who rose to prominence by challenging school closures, mask mandates, and the use of Covid-19 booster shots in children.

The political appointee is a close confidante of Makary's and already has a central role in reshaping vaccine policy. She attended a CDC advisory meeting in place of a career vaccine scientist in April, and reportedly was involved in the approval delay of Novavax's Covid-19 vaccine. Read more about Høeg's rise and background.


biden

What to know about Biden's cancer diagnosis

News of former President Biden's diagnosis with aggressive and incurable prostate cancer shocked the public. The news also spread fast, with all the speculation, confusion, and inappropriate comments that social media is so good for. It didn't help that the news broke days after reporters started writing reviews of a book, out today, on Biden's mental decline over his time in the White House, and efforts by staff to cover it up.

STAT invited Lawrence K. Altman, a physician, and former reporter and medical columnist for the New York Times, to clear the air about the diagnosis.

Based on the public record of Biden's medical care and standard medical recommendations, as recently as a year ago there was no reason to perform screening tests for the disease, despite his age, 81 at the time, Altman writes. The diagnosis underscores the fact that cancers can sometimes pop up suddenly, even among recipients of the most sophisticated care doctors can offer. Read more.


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • UnitedHealth said it was too dangerous for him to be discharged. Days later, it denied his care, STAT
  • These Are the Dueling Republican Factions Imperiling the Party's Megabill, The New York Times
  • Trump's science adviser calls for return to 'gold-standard' research to kickstart stalled advances, STAT
  • Cracks emerge in MAHA-MAGA alliance as RFK Jr. builds out his team of health 'renegades', CNN

Thanks for reading! More next time,


Enjoying D.C. Diagnosis? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments